Metraipolis › archive › dc_d4227959cfbf

Association of Lifetime Exposure to Glyphosate and Aminomethylphosphonic Acid (AMPA) with Liver Inflammation and Metabolic Syndrome at Young Adulthood:… — Europe PMC PMID:36856429

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36856429
DOI
10.1289/ehp11721
License (as archived)
CC0-1.0
Archived
2026-10-07T14:07:51.486Z
SHA-256 of the archived text
4df74836f852106cd59a201ac95d1c215a136d25472b1e2cbaaa50a10f8f84a7
Stable URL of this page
https://metraipolis.com/documento/dc_d4227959cfbf

How to cite

Association of Lifetime Exposure to Glyphosate and Aminomethylphosphonic Acid (AMPA) with Liver Inflammation and Metabolic Syndrome at Young Adulthood:… — Europe PMC PMID:36856429 — Europe PMC (en), https://europepmc.org/article/MED/36856429 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_d4227959cfbf (Metraipolis archive dc_d4227959cfbf, sha256 4df74836f852106cd59a201ac95d1c215a136d25472b1e2cbaaa50a10f8f84a7)
BibTeX
@misc{dcd4227959cfbf,
  title = {Association of Lifetime Exposure to Glyphosate and Aminomethylphosphonic Acid (AMPA) with Liver Inflammation and Metabolic Syndrome at Young Adulthood:… — Europe PMC PMID:36856429},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36856429},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_d4227959cfbf; sha256 4df74836f852106cd59a201ac95d1c215a136d25472b1e2cbaaa50a10f8f84a7},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36856429. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: The prevalence of liver disorders and metabolic syndrome has increased among youth. Glyphosate, the most widely used herbicide worldwide, could contribute to the development of these conditions. Objective: We aimed to assess whether lifetime exposure to glyphosate and its degradation product, aminomethylphosphonic acid (AMPA), is associated with elevated liver transaminases and metabolic syndrome among young adults. Methods: We conducted a prospective cohort study (n=480 mother-child dyads) and a nested case-control study (n=60 cases with elevated liver transaminases and 91 controls) using data from the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS). We measured glyphosate and AMPA concentrations in urine samples collected during pregnancy and at child ages 5, 14, and 18 y from cases and controls. We calculated glyphosate residue concentrations: [glyphosate + (1.5×AMPA)]. We estimated the amount of agricultural-use glyphosate applied within a 1-km radius of every residence from pregnancy to age 5 y for the full cohort using California Pesticide Use Reporting data. We assessed liver transaminases and metabolic syndrome at 18 y of age. Results: Urinary AMPA at age 5 y was associated with elevated transaminases [relative risk (RR) per 2-fold increase=1.27, 95% confidence interval (CI): 1.06, 1.53] and metabolic syndrome (RR=2.07, 95% CI: 1.38, 3.11). Urinary AMPA and glyphosate residues at age 14 y were associated with metabolic syndrome [RR=1.80 (95% CI: 1.10, 2.93) and RR=1.88 (95% CI: 1.03, 3.42), respectively]. Overall, a 2-fold increase in urinary AMPA during childhood was associated with a 14% and a 55% increased risk of elevated liver transaminases and metabolic syndrome, respectively. Living near agricultural glyphosate applications during early childhood (birth to 5 y of age) was also associated with metabolic syndrome at age 18 y in the case-control group (RR=1.53, 95% CI: 1.16, 2.02). Discussion: Childhood exposure to glyphosate and AMPA may increase risk of liver and cardiometabolic disorders in early adulthood, which could lead to more serious diseases later in life. https://doi.org/10.1289/EHP11721.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: Environmental health perspectives, 2023 (prima pubblicazione 2023-03-01).
Identificativi: PMID 36856429 · PMCID PMC9976611 · DOI 10.1289/ehp11721.
Descrittori MeSH principali: Metabolic Syndrome.
Pagina: https://europepmc.org/article/MED/36856429 — https://doi.org/10.1289/ehp11721. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T14:02:28.749Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.